基本信息
views: 812
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
She is a principal investigator of multiple clinical trials focusing on combining novel targeted therapeutics with standard treatment to improve the treatment of both early and late stage breast cancer, and has published widely in this area. Her current research interests include immunotherapy and combinations of targeted agents in the treatment of breast cancer to overcome resistance. She was a member of the steering committee for the EMBRACA and ABRAZO studies that evaluated the efficacy of the PARP inhibitor talazoparib in patients with metastatic breast cancer and germline mutations in BRCA1 and 2. In addition, Dr. Rugo has conducted a number of studies focusing on reducing toxicity from therapy, resulting in approval of scalp cooling to reduce chemotherapy induced hair loss, and a steroid mouthwash to reduce targeted agent stomatitis. She is an investigator and the chair of the Safety Committee for the multicenter adaptively randomized phase II I-SPY2 trial, and serves on the Novel Agents Committee. Dr. Rugo is the co-chair of the Triple Negative Working Group and an active member of the Translational Breast Cancer Research Consortium (TBCRC), and is the principal investigator of several TBCRC trials including a multi-center immunotherapy trial funded by the Breast Cancer Research Foundation (BCRF). She is an active member of the Alliance (formerly CALGB) Breast Committee, as well as ASCO, where she serves on the Guidelines Committee and as an editor for the Education Committee.
In addition to her research, Dr. Rugo is an active clinician, and is committed to education, regularly lecturing locally, nationally and internationally on subjects relating to the treatment of and supportive care for breast cancer. At UCSF, Dr. Rugo runs the Breast Forum, an open bimonthly evening educational session for breast cancer patients, families and friends from throughout the bay area.
Dr. Rugo graduated from the University of Pennsylvania School of Medicine in 1983. She completed a residency in internal medicine and primary care followed by a fellowship in hematology and oncology at the University of California San Francisco. She was a post-doctoral fellow in immunology participating in laboratory research at Stanford University from 1988-1990. In 1990, Dr. Rugo joined the faculty at UCSF in the Division of Hematology and Oncology. Dr. Rugo recognized for her excellence in both patient care and in teaching of both medical students and training physicians. She has received several awards including the Bank of America Gianini Foundation Award and a UCSF Clinical Cancer Center Investigator Research Program intra-mural award. In 2006, she received an honor for her work in Breast Cancer Research by the Friends of the Breast Care Center and received the Cancer Care physician of the year award in 2010 by the Cancer Care National Organization.
In addition to her research, Dr. Rugo is an active clinician, and is committed to education, regularly lecturing locally, nationally and internationally on subjects relating to the treatment of and supportive care for breast cancer. At UCSF, Dr. Rugo runs the Breast Forum, an open bimonthly evening educational session for breast cancer patients, families and friends from throughout the bay area.
Dr. Rugo graduated from the University of Pennsylvania School of Medicine in 1983. She completed a residency in internal medicine and primary care followed by a fellowship in hematology and oncology at the University of California San Francisco. She was a post-doctoral fellow in immunology participating in laboratory research at Stanford University from 1988-1990. In 1990, Dr. Rugo joined the faculty at UCSF in the Division of Hematology and Oncology. Dr. Rugo recognized for her excellence in both patient care and in teaching of both medical students and training physicians. She has received several awards including the Bank of America Gianini Foundation Award and a UCSF Clinical Cancer Center Investigator Research Program intra-mural award. In 2006, she received an honor for her work in Breast Cancer Research by the Friends of the Breast Care Center and received the Cancer Care physician of the year award in 2010 by the Cancer Care National Organization.
Research Interests
Papers共 1859 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Saya Jacob,Anika Christofferson,Samantha Fisch, Peter Norwood, Paolo Castillo,Hongmei Yu,Gillian Hirst,Hatem Soliman,Rita Nanda,Rita A. Mukhtar,Cheryl Ewing,Melanie Majure,
crossref(2024)
Antonio Giordano,Michail Ignatiadis,Carlos H. Barrios,Francois Clement Bidard,Binghe Xu, Alicia M Vana,Jason Gong, Ariadna Holynskyj, Prashanth Gopalakrishna,Hope S. Rugo
Journal of Clinical Oncologyno. 16_suppl (2024)
K. Jhaveri,A. Bardia,S-A. Im,S. Pernas Simon,M. De Laurentiis, S. Wang, N. Martinez, G. Santos Borges,D.W. Cescon, M. Hattori,Y-S. Lu,E.P. Hamilton,
ESMO Open (2024)
Kashif Ali,Laila Agrawal,Anu Thummala,Kevin Kalinsky, Sami Ali,Sibel Blau,Margaret Block,Michael Danso,Denise Yardley,Jay Andersen, Adrienne Gropper-Waks,Priya Jayachandran,
Cancer Researchno. 9_Supplement (2024): PO1-04
Cancer Researchno. 9_Supplement (2024): GS02-01
Journal of Nuclear Medicine (2024)
Future oncology (London, England)no. 11 (2024): 635-651
Aditya Bardia,Peter Schmid,Sara Tolaney,Frederik Marmé,Javier Cortés, Theresa Valdez, Hao Wang,Wendy Verret,Hope Rugo
Cancer Researchno. 9_Supplement (2024): PO5-21
Journal of clinical oncology : official journal of the American Society of Clinical Oncologyno. 9 (2024): 987-993
Cancer (2024)
Load More
Author Statistics
#Papers: 1837
#Citation: 74382
H-Index: 120
G-Index: 252
Sociability: 9
Diversity: 0
Activity: 26
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn